Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.24.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue:    
Total revenue $ 23,955 $ 20,551
Cost of revenue 10,341 7,020
Gross profit 13,614 13,531
Research and development costs 11,709 10,894
Sales and marketing expenses 12,595 9,358
General and administrative expenses 11,756 9,611
Operating loss (22,446) (16,332)
Other income (expense):    
Other expense, net (29) (22)
Interest income (expense), net 386 (81)
Net loss $ (22,089) $ (16,435)
Net loss per share attributable to common stockholders:    
Basic (in usd per share) $ (0.90) $ (0.68)
Diluted (in usd per share) $ (0.90) $ (0.68)
Weighted average shares outstanding:    
Basic (in shares) 24,605,212 24,181,854
Diluted (in shares) 24,605,212 24,181,854
Product revenue    
Revenue:    
Total revenue $ 10,603 $ 12,789
Service and other revenue    
Revenue:    
Total revenue $ 13,352 $ 7,762